Company news
Simcere Pharmaceutical Group Limited news in 2022
Simcere Pharmaceutical Group Limited's news releases, calls and decks from 2022, newest first.
Phase II/III clinical trial of Simcere's 3CL-targeting anti-SARS-CoV-2 drug candidate complete all patients enrollment
December 20, 2022
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc
September 28, 2022
Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue
September 5, 2022
Simcere Pharma (2096.HK) Announces a Positive Profit Alert
February 23, 2022